RARECast
A podcast by RARECast - Giovedì
548 Episodio
-
Deriving Rare Disease Therapies from Human Plasma
Pubblicato: 18/10/2017 -
Learning to Live with Purpose
Pubblicato: 11/10/2017 -
A Mother's Race to Find a Treatment for Her Daughter's Ultra-Rare Condition
Pubblicato: 04/10/2017 -
Screening for Rare Diseases
Pubblicato: 27/09/2017 -
A Look at the Changing World of Work for People with a Chronic Illness
Pubblicato: 20/09/2017 -
Aligning Interests in Rare Disease Partnerships
Pubblicato: 13/09/2017 -
A Veteran Venture Capitalist Discusses Investing in Rare Disease Drug Development
Pubblicato: 06/09/2017 -
A Patient Group Crafts Guidelines for Working with Pharma
Pubblicato: 30/08/2017 -
Bringing Innovation to Business Models for Rare Disease Drug Development
Pubblicato: 23/08/2017 -
Rethinking Accessibility and Dependency
Pubblicato: 16/08/2017 -
How Simon Wheatcroft, Blinded by a Rare Disease, Became an Ultramarathoner
Pubblicato: 09/08/2017 -
Spark Hoping Its Luxturna Will Become First FDA-Approved Gene Therapy
Pubblicato: 02/08/2017 -
What Rare Patient-Investors Can Learn From Venture Capitalists
Pubblicato: 26/07/2017 -
Novel Effort Delivers Failed DMD Drug to Former Clinical Trial Participants
Pubblicato: 19/07/2017 -
Centogene Seeks to Deliver Diagnoses to Rare Disease Patients Early
Pubblicato: 12/07/2017 -
Albireo Advances Pipeline for Rare Liver and Gastrointestinal Diseases
Pubblicato: 05/07/2017 -
aTyr Pharma Seeks to Modulate Activity in FSHD and Other Rare Disease
Pubblicato: 28/06/2017 -
Summit Pursues A Different Approach to Treating Duchenne
Pubblicato: 21/06/2017 -
Delivering Enzyme Replacement Therapies Across the Blood-Brain Barrier
Pubblicato: 14/06/2017 -
Sangamo Advances Gene Editing Therapies for Multiple Rare Diseases into the Clinic
Pubblicato: 07/06/2017
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.